Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

December 14, 2020

Study Completion Date

September 27, 2022

Conditions
Abortion, SpontaneousAbortion in First TrimesterPain UterusAbortion EarlyAbortion, Missed
Interventions
DRUG

40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block

Women undergoing D\&C in the first trimester for either surgical abortion or miscarriage management will receive 40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block before cervical dilation.

DRUG

20cc 1% lidocaine with 2 units of vasopressin paracervical block

Women undergoing D\&C in the first trimester for either surgical abortion or miscarriage management will be randomly assigned to receive 20cc 1% lidocaine with 2 units of vasopressin paracervical block before cervical dilation.

Trial Locations (2)

92037

Villa La Jolla Clinic, La Jolla

92103

UCSD Medical Offices South, San Diego

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

University of California, San Diego

OTHER

NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o | Biotech Hunter | Biotech Hunter